Viyash Scientific allotted 228,408 equity shares via two ESOP plans following committee approval on November 2, 2026.
The allotment comprised 193,000 shares at ₹86 and 35,408 shares at ₹101, increasing the paid-up capital.
The new shares rank pari-passu with existing equity, and the filing serves as a regulatory compliance disclosure.